Literature DB >> 17237008

[Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].

Laurence Denat1, Lionel Larue.   

Abstract

Mitf protein is a transcription factor involved all along the life of pigmented cells. This protein is located in the center of multiple signaling pathways which control differentiation, morphology, proliferation and survival of the various cells of the melanocyte lineage: melanoblasts, melanocytes and melanoma. Mitf plays a major role in melanoblasts differentiation, by inducing the key enzyme of melanogenesis, tyrosinase, and its secondary enzymes, Tyrp1 and Dct. Mitf regulates morphology and migration of melanocytes, particularly by regulating cytoskeleton organization and cell-cell adhesion. Mitf plays a double role of inducer/repressor of cellular proliferation. This protein inhibits cell cycle progression and prevents non-proper cell division. In few cases, Mitf can also induce cell cycle. A minimal quantity/activity of Mitf is necessary for melanoblast survival. Essential protein of the melanocyte lineage, Mitf was proposed as diagnostic/pronostic marker for cutaneous melanoma. However, could we then consider MITF as the unique marker of such a cancer?

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237008

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

Review 1.  Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.

Authors:  Yunyi Kong; Suresh M Kumar; Xiaowei Xu
Journal:  Arch Pathol Lab Med       Date:  2010-12       Impact factor: 5.534

2.  miR-182 promotes cell proliferation and invasion by inhibiting APC in melanoma.

Authors:  Xilin Liu; Hong Li; Guangzhi Wu; Shusen Cui
Journal:  Int J Clin Exp Pathol       Date:  2018-04-01

3.  Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi.

Authors:  Jianxin Xia; Yanlong Wang; Fuqiu Li; Jinfeng Wang; Yan Mu; Xianglin Mei; Xue Li; Wenjing Zhu; Xianhua Jin; Kai Yu
Journal:  Biomed Rep       Date:  2016-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.